Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo

• 收藏
• 分享

专利权人:

Applied Molecular Transport LLC

发明人:

Mrsny, Randall J.,Mahmood, Tahir

申请号：

AU2020207779

公开号：

AU2020207779A1

申请日:

2020.07.20

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

#$%^&*AU2020207779A120200806.pdf#####ABSTRACT The present disclosure relates to pharmaceutical compositions comprising a non-naturally occurring fusion molecule and one or more pharmaceutically acceptable carriers, formulated for oral delivery to a subject, and designed to provide for improved, effective therapies for treatment of, e.g., inflammatory diseases, autoimmune diseases, cancer, metabolic disorders, and growth deficiency disorders.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/